Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 18.10M P/E - EPS this Y - Ern Qtrly Grth -
Income -12.71M Forward P/E - EPS next Y - 50D Avg Chg -10.00%
Sales 10.24M PEG - EPS past 5Y - 200D Avg Chg -23.00%
Dividend N/A Price/Book 1.38 EPS next 5Y - 52W High Chg -65.00%
Recommedations - Quick Ratio 1.42 Shares Outstanding 3.85M 52W Low Chg 6.00%
Insider Own - ROA -52.71% Shares Float 101.76M Beta 0.33
Inst Own 0.64% ROE -160.47% Shares Shorted/Prior 27.65K/27.96K Price 0.83
Gross Margin 61.50% Profit Margin -124.08% Avg. Volume 103,596 Target Price -
Oper. Margin -105.96% Earnings Date - Volume 60,808 Change -1.06%
About Genetic Technologies Ltd

Genetic Technologies Limited, a molecular diagnostics company, provides predictive genetic testing and risk assessment tools to help physicians manage people's health in the United States, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. It operates in two segments, EasyDNA and GeneType/Corporate. The company offers BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. In addition, the company offers various cancer risk assessment tests under the GeneType for Colorectal Cancer and GeneType for Breast Cancer brand names; and develops other risk assessment tests across a range of diseases, which include colorectal cancer, ovarian cancer, prostate cancer, coronary artery, and type 2 diabetes. Further, it offers genetic testing services, including medical, animal, forensic, and plant testing. The company has research and collaboration agreements with the University of Melbourne, Translational Genomics Research Institute, Memorial Sloan Kettering New York Cambridge University, the Ohio State University, and Shivom. Genetic Technologies Limited was incorporated in 1987 and is headquartered in Fitzroy, Australia.

Genetic Technologies Ltd News
03/26/24 GTG Global Collaborations and Innovation Update
03/25/24 GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised Healthcare
03/08/24 One Genetic Technologies Insider Raised Stake By 20% In Previous Year
02/28/24 GTG to launch U.S. Customer Digital Media Sales Campaign
01/31/24 Launching our most comprehensive test and expanding into new global markets
01/05/24 Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement
09:00 AM Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
12/14/23 GeneType's Groundbreaking Saliva Test Transforms Early Disease Detection, Paving the Way for Personalized Wellness
12/12/23 Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change
11/15/23 Here's Why Shareholders May Want To Be Cautious With Increasing Genetic Technologies Limited's (ASX:GTG) CEO Pay Packet
10/30/23 Gene Business Update: Private Hospital Partnership; Expanded Multi-Test for Australian Market and Commercial Partner for Cancer Clinical Trial
10/18/23 GeneType Predicting Risk of Pancreatic Cancer: Major Breakthrough in Early Detection and Treatment
10/06/23 Knightscope, Soligenix, and Genetic Technologies Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
09/27/23 Genetic Technologies building pathway to profitability
09/27/23 GTG Signs Precision Medicine Pilot with Australia’s Largest Private Hospital Network
09/15/23 Aridis Pharmaceuticals, Inc., Genetic Technologies Limited, and American Resources Corporation Interviews to Air on the RedChip Money Report(R) on Bloomberg TV
09/12/23 Breakthrough: GeneType for Pancreatic Cancer, Melanoma, and Atrial Fibrillation Cleared for Australian Release
09/01/23 Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report® on Bloomberg TV
08/30/23 Annual Results – Momentum Building on our Commercial Plans
08/09/23 Genetic Technologies Limited Announces Updated Investor Presentation
GENE Chatroom

User Image Emacomber15 Posted - 17 hours ago

$GENE Cup and handle forming with a bullish push to end the month 💪🏼

User Image MeiLingZhou Posted - 18 hours ago

$GENE

User Image Freee2surf Posted - 1 day ago

$GENE 🚀 it’s Gene! $PLTR to $30🚀

User Image Valuehunter1 Posted - 1 day ago

$GENE what happened with a deal/contract they promised by the end of Q1 ? Again nothing , just promises ? Maybe tomorrow?

User Image TraderJackson_ Posted - 2 days ago

TTNP Top Squeeze Watch! Keep it on watch for another high volume spike to 12+ $GBNH $GDC $GENE $GETR 11

User Image Brokechump Posted - 2 days ago

$GENE This thing could run up 20 to 30 easy with right volumn and small float. Just need the right push.....

User Image MeiLingZhou Posted - 2 days ago

$GENE

User Image Turkeycock Posted - 2 days ago

$GENE yep, still here

User Image MeiLingZhou Posted - 3 days ago

$GENE https://www.sec.gov/Archives/edgar/data/1166272/000149315224011237/form6-k.htm

User Image Stock_Titan Posted - 3 days ago

$GENE GTG Global Collaborations and Innovation Update https://www.stocktitan.net/news/GENE/gtg-global-collaborations-and-innovation-totq11frjct1.html

User Image CurtTyp3 Posted - 3 days ago

$GENE Business-News-Today.com @cricket_fundas · 24. März Genetic Technologies unveils comprehensive genetic risk assessment test https://business-news-today.com/genetic-technologies-unveils-comprehensive-genetic-risk-assessment-test/ #GeneticTechnologies #GeneticTesting #PersonalizedMedicine #GeneType #PreventativeHealthcare #InnovationInHealth #RiskAssessment

User Image parabolicrunners Posted - 4 days ago

$GENE

User Image Stock_Titan Posted - 4 days ago

$GENE GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised Healthcare https://www.stocktitan.net/news/GENE/gene-to-develop-worlds-most-advanced-comprehensive-risk-test-mab3sbadxtxs.html

User Image Emacomber15 Posted - 4 days ago

$GENE Appointment of new CFO, 2014-2024 cfo of ATHE which from that time successfully brought her companies shares from a high of 797$ down to a low of(conveniently hit this year) 1.55$ a share. Cant wait to see what she can accomplish 🤣 (on the side fr , she’s smart for joining at the bottom not the top this time) https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02788354-3A639336

User Image MeiLingZhou Posted - 6 days ago

$GENE https://www.sec.gov/Archives/edgar/data/1166272/000149315224010906/ex99-1.htm nothing new

User Image Brokechump Posted - 6 days ago

$GENE news at least

User Image Piggly_Wiggly21 Posted - 6 days ago

$GENE they need to raise more money???

User Image MeiLingZhou Posted - 6 days ago

$GENE

User Image MeiLingZhou Posted - 1 week ago

$GENE oof

User Image Brokechump Posted - 1 week ago

$GENE Ummm oh well. Holding.

User Image PuppyAlert Posted - 1 week ago

$GENE

User Image CurtTyp3 Posted - 1 week ago

$GENE Melbourne, Australia, 20 March 2024: Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, ”Company”, “GTG”), a global leader in guideline-driven genomics-based testing in health, wellness and serious diseases, provides the results of the Extraordinary General Meeting held today. The sole resolution put to members was carried with 97.66% of the vote in favour of the resolution. The passing of the resolution provides the Company with additional capacity to raise capital. Voting was conducted by poll, called by the Chairman, pursuant to the Notice of Meeting. Chairman, Peter Rubinstein, commented: “Over 75% of our shareholders voted in favour of the resolution, representing a resounding endorsement of support from our loyal shareholders to continue on this important journey to get the geneType platform in the hands of the masses, with a key focus in the USA. Genomics is no longer just about rare diseases and family history, it is about you and me”.

User Image MeiLingZhou Posted - 1 week ago

$GENE https://www.prnewswire.com/news-releases/gene-panel-market-size-to-grow-by-usd-3-23-million-from-2022-to-2027--north-america-to-account-for-43-of-market-growth-technavio-302092732.html

User Image StockRoomBully Posted - 1 week ago

$LEAS breaking 🗞️🗞️ news $Wena "Redwoods Acquisition Corp. (NASDAQ:RWOD) surges 16%; retail investors who own 42% shares profited along with insiders" Key Insights Significant control over Redwoods Acquisition by retail investors implies that the general public has more power to influence management and governance-related decisions A total of 7 investors have a majority stake in the company with 51% ownership $CRSP $EDIT $NTLA $GENE https://finance.yahoo.com/news/redwoods-acquisition-corp-nasdaq-rwod-111616655.html

User Image Emacomber15 Posted - 1 week ago

$GENE Showtime is at 7:00 EST tonight

User Image MeiLingZhou Posted - 1 week ago

$GENE

User Image PuppyAlert Posted - 1 week ago

$GENE

User Image Brokechump Posted - 1 week ago

$GENE

User Image MeiLingZhou Posted - 1 week ago

$GENE

User Image Emacomber15 Posted - 2 weeks ago

$GENE